A life science recruiter's blog on placing R&D professionals.

  • Pfizer and AstraZeneca: More Loss of Jobs to Come

    Update: Since the merger of Pfizer and AstraZeneca never happened, this post is obsolete. But I will leave it up as it does raise some points about how these mega pharma mergers are not the best for employees: Well, I finally have something to write about again. Lately, I just haven’t had much to say here. But the […]

    Read more.
  • A Hot Biotech Company, Moderna Therapeutics

    I’m writing to introduce you to a hot biotech in Cambridge, Massachusetts that just so happens to also be a client of Clark Executive Search. If you are a follower of FierceBiotech or twitter I am sure you will have heard of Moderna Therapeutics. But if not, here is a bit about them and the […]

    Read more.
  • 23andme and the FDA, a Complicated Matter

    Recently the FDA sent a warning letter to the genetics testing company 23andme to cease marketing itself to the public. This letter has caused a stew to boil in the social media world. Since I follow those in science and especially in genetics for my biotech and pharma executive searches, my twitter stream has been […]

    Read more.
  • Which are the Best Pharma and Biotech Companies in 2013?

    Once again it is list time. Several sites list their 2013 top biotech and pharma companies and I have consolidated the lists here for my readers. In addition, there is a list of the best 2013-biotech startups and a list of the latest IPOs in biotech in 2013. Clark Executive Search is proud that we […]

    Read more.